- Home
- ARCC vs RGC Comparison
ARCC vs RGC Comparison
Compare ARCC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCC | RGC |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.5B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARCC | RGC |
|---|---|---|
| Price | $18.83 | $29.93 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $21.60 | N/A |
| AVG Volume (30 Days) | ★ 7.0M | 179.5K |
| Earning Date | 04-28-2026 | 10-31-2025 |
| Dividend Yield | ★ 10.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.86 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.77 | N/A |
| Revenue Next Year | $2.29 | N/A |
| P/E Ratio | $10.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.40 | $9.39 |
| 52 Week High | $23.42 | $950.00 |
Technical Indicators
Market Signals| Indicator | ARCC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 54.58 |
| Support Level | $18.78 | $22.43 |
| Resistance Level | $20.28 | $37.83 |
| Average True Range (ATR) | 0.39 | 3.74 |
| MACD | 0.15 | 0.25 |
| Stochastic Oscillator | 87.55 | 40.78 |
Price Performance
Historical ComparisonAbout ARCC Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.